ENTPD1 and migraine disorder: From the total Treg subset 8.96 ± 0.83% and 42.4 ± 3.13% of the cells were positive for CD73+ and CD39+, respectively, in the control group whereas in patients with migraine the proportion of these cell was significantly lower.